Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Erica Gomes-DaGama"'
Autor:
John F. Gerecitano, Shanu Modi, Raajit Rampal, Alexander E. Drilon, Matthew G. Fury, Mrinal M. Gounder, James J. Harding, David Michael Hyman, Anna M. Varghese, Martin Henner Voss, Fallon Olga France, Tony Taldone, Erica Gomes DaGama, Mohammad Uddin, Gabriela Chiosis, Jason Stuart Lewis, Serge K. Lyashchenko, Steven M. Larson, Christina Pressl, Mark Dunphy
Publikováno v:
Journal of Clinical Oncology. 33:2537-2537
2537 Background: PU-H71 (PU) is an HSP-90 inhibitor that can be labeled with 124I without altering its biochemical properties. Intratumoral drug concentration can be calculated based on 124I-PU-H71 (*PU) PET imaging, leading to a surrogate marker of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91eb2d478c6938f23e3b47904b5ea9b1
https://doi.org/10.1200/jco.2015.33.15_suppl.2537
https://doi.org/10.1200/jco.2015.33.15_suppl.2537
Autor:
Payal Dixit, Shanu Modi, Mohammad Nasir Uddin, John F. Gerecitano, Mei Hsuan Chen, Tony Taldone, Jason S. Lewis, Komal Jhaveri, Brian Krichevsky, Mary L. Alpaugh, Devika Gajria, Gabriela Chiosis, Naga Vara Kishore Pillarsetty, Mark Dunphy, Erica Gomes DaGama, Steven M. Larson
Publikováno v:
Journal of Clinical Oncology. 31:11076-11076
11076 Background: PU-H71 is a Heat Shock Protein 90 inhibitor that can be labeled with 124I without altering its biochemical properties. Intratumoral drug concentration can be calculated based on 124I-PU-H71 (*PU-H71) region of interest analysis and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91a1a8e159abb18211e259179fdda478
https://doi.org/10.1200/jco.2013.31.15_suppl.11076
https://doi.org/10.1200/jco.2013.31.15_suppl.11076
Publikováno v:
The Journal of Immunology. 190:177.14-177.14
Ample co-stimulatory interactions between antigen-presenting cells and T cells are essential for an effective immune response. Similarly, co-stimulation related immuno-experiences have also been considered critical for the successful tumor eradicatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3edd36e2350ff6296f2a4b261db815cb
https://doi.org/10.4049/jimmunol.190.supp.177.14
https://doi.org/10.4049/jimmunol.190.supp.177.14
Autor:
Steven S. Gross, Danuta Zatorska, Anna Rodina, Katerina Hatzi, Peter Smith-Jones, Kristin Beebe, Erica Gomes DaGama, Ross L. Levine, Ly P. Vu, Gabriela Chiosis, Kamalika Moulick, James H. Ahn, Ari Melnick, Jason S. Lewis, Fabiana Perna, Leandro Cerchietti, Stephen D. Nimer, Nagavarakishore Pillarsetty, Steven M. Larson, Hongliang Zong, Eloisi Caldas-Lopes, Monica L. Guzman, Xinyang Zhao, Hediye Erdjument-Bromage, Len Neckers, Tony Taldone, Thomas Ku, Mary L. Alpaugh
Publikováno v:
Cancer Research. 72:3029-3029
To maintain homeostasis, cells employ intricate molecular machineries comprised of thousands of proteins programmed to execute well-defined functions. Dysregulation of these pathways, through protein mis-expression or mutation, provides biological ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88ab7e9afebfe629b235473eb24491d5
https://doi.org/10.1158/1538-7445.am2012-3029
https://doi.org/10.1158/1538-7445.am2012-3029